E-DRUG: IGFAM - Tiered Pricing Discussion Paper - Not Protectively Marked
--------------------------------------------
IGFAM is the UK Industry Government Forum on Access to Medicines
established to promote dialogue on how industry and government can work
together to promote access to medicines in developing countries. More
details on IGFAM are provided here
http://www.dfid.gov.uk/Global-Issues/Emerging-policy/IGFAM/.
DFID, on behalf of IGFAM, commissioned Professor Prashant Yadav of
MIT-Zaragoza to review current knowledge about differential pricing, its
current prevalence and to suggest ways in which it might be encouraged
in such a way as to enhance access to medicines in low and middle income
developing countries.
IGFAM is interested to solicit the views of stakeholders and other
interested parties on Professor Yadav's paper as a means of stimulating
debate on the issue of differential pricing, and on policies which
governments, donor organisations and industry could adopt to facilitate
access to medicines to poor patients in developing countries. The full
paper and a summary are available here
http://www.dfid.gov.uk/Global-Issues/Emerging-policy/IGFAM/Policy-Issue
s-and-Discussion-Papers/. [link also below]
We would therefore be very grateful if you could take a little time
(less than fifteen minutes) to complete the attached survey
http://www.surveymonkey.com/s/W7XZBMF. [link also below]
Please feel free to add your own comments and suggestions in the space
provided.
The deadline for completing the survey is 14 November.
We will then publish a report based on the responses by the end of
November.
Best wishes
Saul Walker (DFID)
Jon Pender (GSK)
Co-chairs of IGFAM.
Discussion paper -
[http://www.dfid.gov.uk/Global-Issues/Emerging-policy/IGFAM/Policy-Issue
s-and-Discussion-Papers/]
Survey - [http://www.surveymonkey.com/s/W7XZBMF\]